PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Drug doubles down on bone cancer, metastasis

Rice, Baylor's 'BonTarg' combines breast cancer drug with bone-targeting antibody

Drug doubles down on bone cancer, metastasis
2021-06-23
(Press-News.org) HOUSTON - (June 23, 2021) - Bone cancer is hard to treat and prone to metastasis. Research teams at Rice University and Baylor College of Medicine have a new strategy to attack it.

Chemist Han Xiao at Rice and biologist Xiang Zhang at Baylor and their labs have developed an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

Their open-access study, which appears in Science Advances, shows how Xiao's pClick technology can be used to link bone-targeting antibodies and therapeutic molecules.

In experiments, they used pClick to couple a molecule used to treat osteoporosis, alendronate, with the HER2-targeting antibody trastuzumab used to treat breast cancer and found it significantly enhanced the concentration of the antibody at tumor sites.

They reported the combination also inhibited secondary metastasis from infected organs seeded by bone tumors.

"Bone cancer is really challenging to treat, and clinical trials of different treatments have been disappointing for people with bone metastasis," said Xiao, who joined Rice in 2017 with funding from the Cancer Prevention and Research Institute of Texas (CPRIT). "We feel our strategy is a real game changer."

"Getting effective concentrations of drugs to bone tumors has been challenging because bones are hard, their networks of blood vessels is limited and drugs have tended to attach to adjacent healthy tissues," Zhang said.

The new strategy employs bisphosphonates, a class of drugs typically used to treat osteoporosis. Bisphosphonates have a high binding affinity for hydroxyapatite, the main component of hard bone, and help overcome physical and biological barriers in the bone microenvironment.

They're also amenable to binding with drugs through pClick, which uses a cross-linker to snap to specific sites on antibodies without having to re-engineer them with harmful chemicals, enzymes or ultraviolet light.

The result is a molecule that seeks out bone tumors and stays put, giving the drug time to kill tumor cells. It helps that bisphosphonate molecules prefer acidic sites like bone tumors, keeping the drug concentration higher there than in surrounding healthy tissue.

The researchers chose breast cancer drugs because while many recover from the disease, 20 to 40% of breast cancer survivors eventually suffer metastases to distant organs, with metastasis to bone occurring in about 70% of these cases, significantly increasing mortality, they said.

While chemotherapy, hormone and radiation therapy used to treat women with bone metastatic breast cancers can shrink or slow bone metastasis, they usually do not eliminate the metastases, Xiao said.

"Bone is kind of a fertile soil for cancer cell," Xiao said. "If a cancer cell reaches it, then it has a really good chance to grow and to further migrate, for example to the brain, the heart, the liver or to other tissues. That's a really bad situation for a patient."

Xiao hopes to get the compound into a clinical trial, and sees potential for custom conjugates that treat other tumors prone to metastasis, including prostate cancer.

Postdoctoral researchers Zeru Tian of Rice and Ling Wu of Baylor are co-lead authors of the paper. Co-authors are graduate students Chenfei Yu, Yuda Chen, Axel Loredo and Kuan-Lin Wu and postdoctoral researcher Lushun Wang of Rice; and postdoctoral fellows Zhan Xu, Igor Bado and Weijie Zhang and instructor Hai Wang of Baylor.

Xiao is the Norman Hackerman-Welch Young Investigator, the Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research and an assistant professor of chemistry, bioengineering and biosciences. Zhang is the William T. Butler, M.D., Endowed Chair for Distinguished Faculty, McNair Scholar, associate director of the Lester and Sue Smith Breast Center, professor of molecular and cellular biology and member of the Dan L Duncan Comprehensive Cancer Center.

The research was supported by CPRIT, the National Institutes of Health, the Robert A. Welch Foundation, the U.S. Department of Defense, the John S. Dunn Foundation, the Hamill Foundation, the Breast Cancer Research Foundation and the McNair Medical Institute.

INFORMATION:

Read the abstract at https://advances.sciencemag.org/lookup/doi/10.1126/sciadv.abf2051.

This news release can be found online at https://news-network.rice.edu/news/2021/06/23/drug-doubles-down-on-bone-cancer-metastasis/

Follow Rice News and Media Relations via Twitter @RiceUNews.

Related materials: Antibodies get easy upgrade with pClick: http://news.rice.edu/2018/11/05/antibodies-get-easy-upgrade-with-pclick-2/

Rice lab turns fluorescent tags into cancer killers: http://news.rice.edu/2020/06/11/rice-lab-turns-fluorescent-tags-into-cancer-killers-2/

Xiao Lab: https://xiao.rice.edu/People/hanxiao/hanxiao.html

Xiang Zhang Lab: https://www.bcm.edu/research/labs-and-centers/faculty-labs/xiang-zhang-lab

Images for download:

https://news-network.rice.edu/news/files/2021/05/0517_BONE-1-WEB.jpg Scientists at Rice University and Baylor College of Medicine are using pClick conjugation to create therapeutic antibodies that target bone cancers. The conjugate incorporates bisphosphonate molecules that bind to the bone hydroxyapatite matrix. (Credit: Baylor College of Medicine/Rice University)

https://news-network.rice.edu/news/files/2021/05/0517_BONE-2-WEB.jpg MicroCT scans of rodents show those treated with the conjugate of trastuzumab and alendronate (far right), created at Rice University and Baylor College of Medicine, fared far better than those treated with phosphate-buffered saline (PBS) or alendronate (ALN) or trastuzumab (Tras) alone 82 days after tumor implantation. (Credit: Baylor College of Medicine/Rice University)

https://news-network.rice.edu/news/files/2021/05/0517_BONE-34-WEB.jpg Xiang Zhang, left, at Baylor College of Medicine, and Han Xiao at Rice University have developed an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis. (Credit: Rice University/Baylor College of Medicine)

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,978 undergraduates and 3,192 graduate students, Rice's undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 1 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger's Personal Finance.

Baylor College of Medicine (http://www.bcm.edu) in Houston is recognized as a health sciences university and is known for excellence in education, research and patient care. It is the only private medical school in the greater southwest and is ranked 22ndamong medical schools for research and 17th for primary care by U.S. News & World Report. Baylor is listed 20th among all U.S. medical schools for National Institutes of Health funding and No. 1 in Texas. Located in the Texas Medical Center, Baylor has affiliations with seven teaching hospitals and jointly owns and operates Baylor St. Luke's Medical Center, part of CHI St. Luke's Health. Currently, Baylor has more than 3,000 trainees in medical, graduate, nurse anesthesia, physician assistant, orthotics and genetic counseling as well as residents and postdoctoral fellows. Follow Baylor College of Medicine on Facebook (http://www.facebook.com/BaylorCollegeOfMedicine) and Twitter (http://twitter.com/BCMHouston).


[Attachments] See images for this press release:
Drug doubles down on bone cancer, metastasis

ELSE PRESS RELEASES FROM THIS DATE:

Cancer survivors' tongues less sensitive to tastes than those of healthy peers

Cancer survivors tongues less sensitive to tastes than those of healthy peers
2021-06-23
Most survivors of squamous cell head and neck cancers report that their sense of taste is dulled, changed or lost during radiation treatment, causing them to lose interest in eating and diminishing their quality of life. In a study of taste and smell dysfunction with 40 cancer survivors, scientists at the University of Illinois Urbana-Champaign found that the tips of these individuals' tongues were significantly less sensitive to bitter, salty or sweet tastes than peers in the control group who had never been diagnosed with cancer. In a paper published in the journal Chemical Senses, the U. of I. team said this diminished taste sensitivity suggested that the taste ...

Cold weather cost New England electric customers nearly $1.8 billion in one month; A new study suggests ways to mitigate fuel shortages

2021-06-23
In New England, constraints in the supply of natural gas have led to nearly a quarter of all unscheduled power plant outages. In a new study, researchers used data from power plant failures in the 2010s to develop a supply curve of the costs required for generators to mitigate fuel shortages in the region. The study found that storing both oil and gas on-site could reduce dependence by power plants on gas grids in geographic areas with few pipelines. The study was conducted by researchers at Carnegie Mellon University (CMU), The Pennsylvania State University, and the North American Electric Reliability Corporation. It is published in The Electricity Journal. "Gas ...

You can have too much of a good thing, says study financial analysts' work-life balance

You can have too much of a good thing, says study financial analysts work-life balance
2021-06-23
Toronto - Last winter, Goldman Sachs reported it was working to make things better after a group of junior analysts revolted against 100-hour work weeks. That's a smart thing to do, suggests a new study from the University of Toronto's Rotman School of Management. Drawing from more than 6,000 employee reviews of their workplaces and data on their firms' forecasting accuracy, the research shows that making improvements to hardworking analysts' work-life balance produces dividends for the company and for the analysts' careers. "There is a lot of anecdotal evidence, but here we provide large-scale evidence that supports the recent push to grant these employees at least some reprieve from the extremes of their jobs," said Ole-Kristian Hope, who is the Deloitte Professor of Accounting ...

GSA's journal's add seven articles on COVID-19 and aging

2021-06-23
The Gerontological Society of America's highly cited, peer-reviewed journals are continuing to publish scientific articles on COVID-19. The following were published between May 4 and June 14; all are free to access: Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19: Research article in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences by Jose Manuel Ramos-Rincón, MD, PhD, Luis M. Pérez-Belmonte, MD, PhD, Francisco Javier Carrasco-Sánchez, MD, PhD, Sergio Jansen-Chaparro, MD, PhD, Mercedes De-Sousa-Baena, MD, José Bueno-Fonseca, MD, ...

Cat-borne parasite Toxoplasma induces fatally bold behavior in hyena cubs

Cat-borne parasite Toxoplasma induces fatally bold behavior in hyena cubs
2021-06-23
Best known for its presence in house cats and a tendency to infect and alter the behaviors of rodents and humans, the parasite Toxoplasma gondii (T. gondii) is also associated with bold behavior among wild hyena cubs and risk of death during interactions with lions, finds new research from the University of Colorado Boulder. The findings, published this week in Nature Communications, reinforce previous research which has found the parasite can prompt profound behavioral changes in its hosts, and potentially in the 2 billion people worldwide estimated to be infected by it. While T. gondii has been well studied in laboratory settings with humans and wild-caught ...

Nature article: Dieting and its effect on the gut microbiome

Nature article: Dieting and its effect on the gut microbiome
2021-06-23
Researchers from Charité - Universitätsmedizin Berlin and the University of California in San Francisco were able to show for the first time that a very low calorie diet significantly alters the composition of the microbiota present in the human gut. In a current Nature* publication, the researchers report that dieting results in an increase of specific bacteria - notably Clostridioides difficile, which is associated with antibiotic-induced diarrhea and colitis. These bacteria apparently affect the body's energy balance by exerting an influence on the absorption of nutrients ...

NIH scientists describe "Multi-Kingdom Dialogue" between internal, external microbiota

NIH scientists describe Multi-Kingdom Dialogue between internal, external microbiota
2021-06-23
WHAT: National Institutes of Health scientists and their collaborators have identified an internal communication network in mammals that may regulate tissue repair and inflammation, providing new insights on how diseases such as obesity and inflammatory skin disorders develop. The new research is published in Cell. The billions of organisms living on body surfaces such as the skin of mammals--collectively called microbiota--communicate with each other and the host immune system in a sophisticated network. According to the study, viruses integrated in the host genome, remnants of previous infections called endogenous retroviruses, can ...

Melatonin in mice: there's more to this hormone than sleep

Melatonin in mice: theres more to this hormone than sleep
2021-06-23
Researchers at the RIKEN Center for Brain Science and the RIKEN BioResource Research Center in Japan, along with collaborators at the State University of New York at Buffalo, have created a mouse model that allows the study of naturally occurring melatonin. Published in the Journal of Pineal Research, these first experiments using the new mice showed that natural melatonin was linked to a pre-hibernation state that allows mice to slow down their metabolism and survive when food is scarce, or temperatures are cold. Melatonin is called "the hormone of darkness" because it's released by the brain in the dark, which usually means at night. It tells the body when it's dark outside so that the body can switch to 'night mode'. Although other hormones are easily studied in the laboratory, ...

Wild bees need deadwood in the forest

Wild bees need deadwood in the forest
2021-06-23
How many tree species are there in the forest? How are the trees scattered throughout? How high are the individual tree crowns? Are there fallen trees or hollowed-out tree trunks? Forest scientists characterize forests according to structural factors. "Structural richness is very important for biodiversity in forests. But forests used for forestry are generally poor in terms of structure," says Tristan Eckerter from the Chair of Nature Conservation and Landscape Ecology at the University of Freiburg. Therefore, together with research teams from the Chair of Silviculture and the Black Forest National Park, he investigated ...

A triple-system neural model of maladaptive consumption

2021-06-23
A new article published in the Journal of the Association for Consumer Research presents a neural model of maladaptive consumption. Consumption (of, for instance, substances, food, and online media) is driven mainly by expected rewards that stem from the ability of the consumption act to satisfy intrinsic (e.g., curiosity) and extrinsic (e.g., job performance) needs. In the article, "A Triple-System Neural Model of Maladaptive Consumption," the authors define maladaptive consumption as a state of compulsive seeking and consumption of rewarding products or experiences, which are sustained despite the negative consequences of such behaviors. "Understanding the neural basis of maladaptive ...

LAST 30 PRESS RELEASES:

Anthropologist documents how women and shepherds historically reduced wildfire risk in Central Italy

Living at higher altitudes in India linked to increased risk of childhood stunting

Scientists discover a new signaling pathway and design a novel drug for liver fibrosis

High-precision blood glucose level prediction achieved by few-molecule reservoir computing

The importance of communicating to the public during a pandemic, and the personal risk it can lead to

Improving health communication to save lives during epidemics

Antimicrobial-resistant hospital infections remain at least 12% above pre-pandemic levels, major US study finds

German study finds antibiotic use in patients hospitalised with COVID-19 appears to have no beneficial effect on clinical outcomes

Targeting specific protein regions offers a new treatment approach in medulloblastoma

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Cardiovascular societies propel plans forward for a new American Board of Cardiovascular Medicine

Hebrew SeniorLife selected for nationwide collaborative to accelerate system-wide spread of age-friendly care for older adults

New tool helps identify babies at high-risk for RSV

Reno/Sparks selected to be part of Urban Heat Mapping Campaign

Advance in the treatment of acute heart failure identified

AGS honors Dr. Rainier P. Soriano with Dennis W. Jahnigen Memorial Award at #AGS24 for proven excellence in geriatrics education

New offshore wind turbines can take away energy from existing ones

Unprecedented research probes the relationship between sleep and memory in napping babies and young children

Job losses help explain increase in drug deaths among Black Americans

Nationwide, 32 local schools win NFL PLAY 60 grants for physical activity

Exposure to noise – even while in the egg – impairs bird development and fitness

Vitamin D availability enhances antitumor microbes in mice

Conservation actions have improved the state of biodiversity worldwide

Corporate emission targets are incompatible with global climate goals

Vitamin D alters mouse gut bacteria to give better cancer immunity

Escape the vapes: scientists call for global shift to curb consumer use of disposable technologies

First-of-its-kind study definitively shows that conservation actions are effective at halting and reversing biodiversity loss

A shortcut for drug discovery

Food in sight? The liver is ready!

Climate change could become the main driver of biodiversity decline by mid-century

[Press-News.org] Drug doubles down on bone cancer, metastasis
Rice, Baylor's 'BonTarg' combines breast cancer drug with bone-targeting antibody